EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: History, Myths, and Realities Between Past and Future

Riccardo Urgesi, Cristiano Pagnini iD, Maria Carla Di Paolo, Lorella Pallotta, Gianfranco Fanello, Pavlos Antypas, Elio Pietro Perrone, Giuseppe Villotti, Andrea D'Amico, Fernando De Angelis, Maria Giovanna Graziani

Medical Sciences · 19.07.2026 · 14 (3) · 405

DOI: 10.3390/medsci14030405 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 19.07.2026. Verfasst von Riccardo Urgesi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, S. Giovanni Addolorata Hospital, 00184 Rome, Italy. Hauptthemen laut MEDLINE: Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Adenocarcinoma, Mucinous. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas is among the most clinically relevant and conceptually intricate precancerous lesions encountered in modern gastroenterology. First identified in the early 1980s as a “mucin-producing tumor,” IPMN has since undergone a profound redefinition: from an obscure and poorly classified entity to a well-established precursor of pancreatic ductal adenocarcinoma (PDAC), shaped by characteristic molecular alterations such as KRAS, GNAS, and RNF43 mutations. Over the past two decades, the reported incidence of IPMN has risen sharply, a trend largely attributable to the widespread use of high-resolution cross-sectional imaging rather than a genuine increase in disease prevalence. IPMNs are categorized anatomically into main-duct (MD-IPMN), branch-duct (BD-IPMN), and mixed-type forms and histologically into gastric, intestinal, pancreatobiliary, and oncocytic subtypes, each associated with distinct malignant potential and prognostic implications. International consensus guidelines (Sendai 2006; Fukuoka 2012; Fukuoka revision 2017; Kyoto 2024) have progressively refined strategies for risk stratification and surgical decision-making. Nevertheless, significant debate persists regarding optimal surveillance intervals, thresholds for resection, and the management of low-risk branch-duct lesions. This review offers a comprehensive and critically evaluated synthesis about IPMN, spanning its historical recognition, molecular pathogenesis, epidemiology, clinical manifestations, diagnostic evaluation, pathological features, differential diagnosis, surveillance paradigms, long-term complications, associated conditions, therapeutic options, and future directions. Particular attention is given to longstanding “myths” that have influenced clinical practice and to emerging “realities” grounded in contemporary molecular and clinical evidence. Our aim is to provide physicians with a clear and updated framework for navigating the complexities of IPMN management in current practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic Intraductal NeoplasmsPancreatic NeoplasmsCarcinoma, Pancreatic DuctalAdenocarcinoma, MucinousHumans

Stichwörter der Autor:innen

GNASKRASadenoma–carcinoma sequencefield defectintraductal papillary mucinous neoplasmpancreatic cystic neoplasmpancreatic ductal adenocarcinomasurveillance

Autor:innen und Institutionen

  • Gastroenterology Department, S. Giovanni Addolorata Hospital, 00184 Rome, Italy.
  • Gastroenterology and Endoscopy Unit, Campus Bio Medico, University of Rome, 00128 Rome, Italy.
  • S. Carlo di Nancy Hospital, 00165 Rome, Italy.

ORCID-Profile: Cristiano Pagnini

Zitieren

APA

Urgesi, R., Pagnini, C., Di Paolo, M. C., Pallotta, L., Fanello, G., Antypas, P., Perrone, E. P., Villotti, G., D'Amico, A., De Angelis, F., & Graziani, M. G. (2026). Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: History, Myths, and Realities Between Past and Future. Medical Sciences, 14(3), 405. https://doi.org/10.3390/medsci14030405

Vancouver

Urgesi R, Pagnini C, Di Paolo MC, Pallotta L, Fanello G, Antypas P, et al. Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: History, Myths, and Realities Between Past and Future. Medical Sciences. 2026;14(3):405. doi:10.3390/medsci14030405

BibTeX
@article{Urgesi2026,
  author = {Urgesi, Riccardo and Pagnini, Cristiano and Di Paolo, Maria Carla and Pallotta, Lorella and Fanello, Gianfranco and Antypas, Pavlos and Perrone, Elio Pietro and Villotti, Giuseppe and D'Amico, Andrea and De Angelis, Fernando and Graziani, Maria Giovanna},
  title = {Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: History, Myths, and Realities Between Past and Future},
  journal = {Medical Sciences},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {405},
  doi = {10.3390/medsci14030405}
}
Kostenlos starten →